πŸ‡ΊπŸ‡Έ FDA
Patent

US 7807659

Caspase inhibitors and uses thereof

granted A61PA61P1/00A61P1/02

Quick answer

US patent 7807659 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16